Carecloud Pref Share CCLDO 8.75 Prep 02/15/24 B | 8-K: FY2025 Q3 Revenue: USD 31.07 M

Revenue: As of FY2025 Q3, the actual value is USD 31.07 M.

EPS: As of FY2025 Q3, the actual value is USD 0.04.

EBIT: As of FY2025 Q3, the actual value is USD 3.262 M.

Revenue for Q3 2025: $31.1 million, up 9% YoY from $28.5 million in Q3 2024.
Revenue for the first nine months of 2025: $86.1 million, up 4% YoY from $82.6 million in the same period of 2024.

GAAP Net Income for Q3 2025: $3.1 million, consistent with Q3 2024.
GAAP Net Income for the first nine months of 2025: $7.9 million, up 74% YoY from $4.6 million in the same period of 2024.
Adjusted Net Income for Q3 2025: $4.4 million, up 27% YoY from $3.5 million in Q3 2024.
Adjusted Net Income for the first nine months of 2025: $10.0 million, up 50% YoY from $6.6 million in the same period of 2024.
Adjusted EBITDA for Q3 2025: $7.7 million, up 13% YoY from $6.8 million in Q3 2024.
Adjusted EBITDA for the first nine months of 2025: $19.9 million, up 17% YoY from $16.9 million in the same period of 2024.

Net Cash Provided by Operating Activities for the first nine months of 2025: $19.9 million, up from $15.4 million in the same period of 2024.
Net Cash Used in Investing Activities for the first nine months of 2025: - $21.2 million, up from - $5.1 million in the same period of 2024.
Net Cash Provided by Financing Activities for the first nine months of 2025: $1.2 million, up from - $10.7 million in the same period of 2024.

Preferred Stock Dividends Paid for the first nine months of 2025: $4.8 million.
Line of Credit Borrowing Reduced to: $4.9 million from $8.3 million.

Full-Year 2025 Revenue Guidance: Increased to $117 – $119 million, up from the initial range of $111 – $114 million.
Adjusted EBITDA for Full-Year 2025: Expected to be $26 – $28 million.
Net Income Per Share (EPS) for Full-Year 2025: Expected to be $0.10 - $0.13.

Revenue: As of FY2025 Q3, the actual value is USD 31.07 M.

EPS: As of FY2025 Q3, the actual value is USD 0.04.

EBIT: As of FY2025 Q3, the actual value is USD 3.262 M.

Revenue for Q3 2025: $31.1 million, up 9% YoY from $28.5 million in Q3 2024.
Revenue for the first nine months of 2025: $86.1 million, up 4% YoY from $82.6 million in the same period of 2024.

GAAP Net Income for Q3 2025: $3.1 million, consistent with Q3 2024.
GAAP Net Income for the first nine months of 2025: $7.9 million, up 74% YoY from $4.6 million in the same period of 2024.
Adjusted Net Income for Q3 2025: $4.4 million, up 27% YoY from $3.5 million in Q3 2024.
Adjusted Net Income for the first nine months of 2025: $10.0 million, up 50% YoY from $6.6 million in the same period of 2024.
Adjusted EBITDA for Q3 2025: $7.7 million, up 13% YoY from $6.8 million in Q3 2024.
Adjusted EBITDA for the first nine months of 2025: $19.9 million, up 17% YoY from $16.9 million in the same period of 2024.

Net Cash Provided by Operating Activities for the first nine months of 2025: $19.9 million, up from $15.4 million in the same period of 2024.
Net Cash Used in Investing Activities for the first nine months of 2025: - $21.2 million, up from - $5.1 million in the same period of 2024.
Net Cash Provided by Financing Activities for the first nine months of 2025: $1.2 million, up from - $10.7 million in the same period of 2024.

Preferred Stock Dividends Paid for the first nine months of 2025: $4.8 million.
Line of Credit Borrowing Reduced to: $4.9 million from $8.3 million.

Full-Year 2025 Revenue Guidance: Increased to $117 – $119 million, up from the initial range of $111 – $114 million.
Adjusted EBITDA for Full-Year 2025: Expected to be $26 – $28 million.
Net Income Per Share (EPS) for Full-Year 2025: Expected to be $0.10 - $0.13.